Skip to Main Content

Paper Details

Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF.
Circulation
21
2021
Author NameAffiliation
Gary Michael FelkerDuke Clinical Research Institute and Duke University School of Medicine
Ileana L Pi??aWayne State University
Alan S MaiselUniversity of California-San Diego (A.M.).
  • 1 - 3

Datasets

Release 1.2